JP6110591B2 - ｃＡＭＰのためのルシフェラーゼバイオセンサー - Google Patents

ｃＡＭＰのためのルシフェラーゼバイオセンサー Download PDF

Info

Publication number
JP6110591B2
JP6110591B2 JP2011510512A JP2011510512A JP6110591B2 JP 6110591 B2 JP6110591 B2 JP 6110591B2 JP 2011510512 A JP2011510512 A JP 2011510512A JP 2011510512 A JP2011510512 A JP 2011510512A JP 6110591 B2 JP6110591 B2 JP 6110591B2
Authority
JP
Japan
Prior art keywords
luciferase
seq
residues
camp
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011510512A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011520466A (ja
JP2011520466A5 (enExample
Inventor
ブロック ビンコウスキー
ブロック ビンコウスキー
ランス ピー エンセル
ランス ピー エンセル
モニカ ジー ウッド
モニカ ジー ウッド
キース ヴィー ウッド
キース ヴィー ウッド
クリス ツィンマーマン
クリス ツィンマーマン
ポール オットー
ポール オットー
ゲディミナス ヴィデュギリス
ゲディミナス ヴィデュギリス
ピート ステーシャ
ピート ステーシャ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Promega Corp
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Publication of JP2011520466A publication Critical patent/JP2011520466A/ja
Publication of JP2011520466A5 publication Critical patent/JP2011520466A5/ja
Application granted granted Critical
Publication of JP6110591B2 publication Critical patent/JP6110591B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/008—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions for determining co-enzymes or co-factors, e.g. NAD, ATP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G01N33/5735—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes co-enzymes or co-factors, e.g. NAD, ATP
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
    • C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/90241—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP2011510512A 2008-05-19 2009-05-19 ｃＡＭＰのためのルシフェラーゼバイオセンサー Active JP6110591B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5437408P 2008-05-19 2008-05-19
US61/054,374 2008-05-19
US11998308P 2008-12-04 2008-12-04
US61/119,983 2008-12-04
PCT/US2009/003132 WO2009142735A2 (en) 2008-05-19 2009-05-19 LUCIFERASE BIOSENSORS FOR cAMP

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014266438A Division JP6275635B2 (ja) 2008-05-19 2014-12-26 ｃＡＭＰのためのルシフェラーゼバイオセンサー

Publications (3)

Publication Number Publication Date
JP2011520466A JP2011520466A (ja) 2011-07-21
JP2011520466A5 JP2011520466A5 (enExample) 2016-10-27
JP6110591B2 true JP6110591B2 (ja) 2017-04-05

Family

ID=41202867

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011510512A Active JP6110591B2 (ja) 2008-05-19 2009-05-19 ｃＡＭＰのためのルシフェラーゼバイオセンサー
JP2014266438A Active JP6275635B2 (ja) 2008-05-19 2014-12-26 ｃＡＭＰのためのルシフェラーゼバイオセンサー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014266438A Active JP6275635B2 (ja) 2008-05-19 2014-12-26 ｃＡＭＰのためのルシフェラーゼバイオセンサー

Country Status (5)

Country Link
US (2) US9045730B2 (enExample)
EP (1) EP2281046B1 (enExample)
JP (2) JP6110591B2 (enExample)
AT (1) ATE542903T1 (enExample)
WO (1) WO2009142735A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2298902B1 (en) 2003-10-10 2015-04-22 Promega Corporation Luciferase biosensor
JP5684984B2 (ja) 2006-04-03 2015-03-18 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 順列置換及び非順列置換ルシフェラーゼバイオセンサー
ATE542903T1 (de) 2008-05-19 2012-02-15 Promega Corp Luciferase-biosensoren für camp
KR101665352B1 (ko) * 2009-05-01 2016-10-12 프로메가 코포레이션 광 출력이 향상된 합성 오플로포러스 루시퍼라제
US9290794B2 (en) 2010-05-11 2016-03-22 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
EP2569423B1 (en) 2010-05-11 2015-12-02 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
AU2011323418B2 (en) 2010-11-02 2017-07-27 Promega Corporation Novel coelenterazine substrates and methods of use
EP2635583B1 (en) 2010-11-02 2015-06-03 Promega Corporation Coelenterazine derivatives and methods of using same
WO2012071631A1 (en) * 2010-12-03 2012-06-07 Gene Stream Pty Ltd Improved light-emitting molecules
EP2825887A4 (en) 2012-03-15 2015-08-19 Montana Molecular Llc GENETICALLY-CODED, FLUORESCENT SENSORS FOR THE DETECTION OF INTRA-CELLULAR SIGNALS BY DIACYLGLYCEROL SIGNAL PATHS
JP2015000021A (ja) * 2013-06-14 2015-01-05 浜松ホトニクス株式会社 細胞内ｃＡＭＰ濃度を制御する方法
JP6484987B2 (ja) 2013-10-21 2019-03-20 Jnc株式会社 エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法
CA2929392A1 (en) 2013-11-04 2015-05-07 Montana Molecular Llc Genetically encoded fluorescent sensors for detecting ligand bias and intracellular signaling through camp pathways
US9927430B2 (en) 2014-01-29 2018-03-27 Promega Corporation Pro-substrates for live cell applications
JP6703484B2 (ja) 2014-01-29 2020-06-03 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 細胞による取り込み測定のための、標識用試薬としての、キノンでマスクされたプローブ
JP6265020B2 (ja) 2014-04-16 2018-01-24 Jnc株式会社 エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法
US10316070B2 (en) 2016-09-09 2019-06-11 Promega Corporation Dual protected pro-coelenterazine substrates
WO2020050208A1 (ja) * 2018-09-05 2020-03-12 ヤマサ醤油株式会社 Ｔｓｈ受容体に対する自己抗体活性の迅速測定方法及びキット
KR20220002883A (ko) * 2019-03-12 2022-01-07 퀴델 코포레이션 자가항체 검출용 조성물, 키트, 및 방법
US20210318292A1 (en) * 2020-04-13 2021-10-14 Sensorium Bio, Inc. System and Method to Detect Small Molecules
US20240174992A1 (en) 2022-05-04 2024-05-30 Promega Corporation Split modified dehalogenase variants
JP2025515179A (ja) 2022-05-04 2025-05-13 プロメガ コーポレイション 円順列置換デハロゲナーゼバリアント
WO2025100444A1 (ja) * 2023-11-07 2025-05-15 株式会社コスミックコーポレーション Ｔｓｈ活性測定用のレポーター細胞

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO864301L (no) * 1986-10-28 1988-04-29 Tore Jahnsen Dna-prober for human regulatorisk enhet av camp-avhengige proteinkinaser.
WO1990005745A1 (en) * 1988-11-18 1990-05-31 The General Hospital Corporation A cAMP-RESPONSIVE TRANSCRIPTIONAL ENHANCER BINDING PROTEIN
US5683888A (en) * 1989-07-22 1997-11-04 University Of Wales College Of Medicine Modified bioluminescent proteins and their use
GB8916806D0 (en) 1989-07-22 1989-09-06 Univ Wales Medicine Modified proteins
FR2682122B1 (fr) 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
DE69535744T2 (de) 1994-01-03 2009-07-02 Promega Corp., Madison Mutierte luziferasen
CA2196496A1 (en) * 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
US6294330B1 (en) * 1997-01-31 2001-09-25 Odyssey Pharmaceuticals Inc. Protein fragment complementation assays for the detection of biological or drug interactions
US7312302B2 (en) 1997-02-20 2007-12-25 Oncolmmunin, Inc. Compositions for the detection of enzyme activity in biological samples and methods of use thereof
US6037137A (en) 1997-02-20 2000-03-14 Oncoimmunin, Inc. Fluorogenic peptides for the detection of protease activity
US6602677B1 (en) * 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
JP4537573B2 (ja) * 1997-09-19 2010-09-01 プロメガ・コーポレイシヨン 熱安定ルシフェラーゼと生産方法
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
US6884870B2 (en) 1998-03-20 2005-04-26 California Institute Of Technology Fusion proteins for identifying proteases, protease target sites and regulators of protease activity in living cells
US6855515B1 (en) 1998-04-22 2005-02-15 Merck & Co., Inc. Autoantigenic fragments, methods and assays
GB9819666D0 (en) 1998-09-09 1998-11-04 Univ Aberdeen Biosensor
US20020192719A1 (en) * 1998-09-30 2002-12-19 Caliper Technologies Corp. Homogeneous assay methods
WO2000024768A2 (en) 1998-10-23 2000-05-04 Massachusetts Institute Of Technology Genes integrating signal transduction pathways
GB9823468D0 (en) 1998-10-28 1998-12-23 Secr Defence Novel enzyme
US6670144B1 (en) * 1999-02-26 2003-12-30 Cyclacel, Ltd. Compositions and methods for monitoring the phosphorylation of natural binding partners
JP3059435B1 (ja) * 1999-03-18 2000-07-04 扶桑薬品工業株式会社 ｃＡＭＰおよびアデニル酸シクラ―ゼの酵素的蛍光定量アッセイ
US6573059B1 (en) * 1999-06-04 2003-06-03 Rmf Dictagene S.A. Use of the regulatory subunit of the camp dependent protein kinase (PKA) from dictyostelium for camp measurements
US7109315B2 (en) * 2000-03-15 2006-09-19 Bruce J. Bryan Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
US6808874B2 (en) * 2000-06-13 2004-10-26 Cyclacel Ltd. Methods of monitoring enzyme activity
US6890745B1 (en) 2000-07-19 2005-05-10 Chemicon International, Inc. Protease specific cleavable luciferases and methods of use thereof
US7166447B2 (en) * 2000-07-26 2007-01-23 Japan Science And Technology Corporation Probe for analyzing protein—protein interaction and method of analyzing protein—protein interactions with the use of the same
US6541196B2 (en) * 2000-07-26 2003-04-01 Jackson State University Method for cAMP production
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
US20020073441A1 (en) 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
US7083911B2 (en) * 2001-02-16 2006-08-01 Promega Corporation Method for detection of ATP
US20030053995A1 (en) 2001-06-15 2003-03-20 Mien-Chie Hung Methods and compositions for inhibiting EGF receptor activity
AU2002364124A1 (en) 2001-11-28 2003-06-10 The Burnham Institute Methods for identifying modulators of apoptosis
US7927871B2 (en) 2002-01-29 2011-04-19 Oncoimmunin, Inc. Visualization and quantitation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
AU2003216207A1 (en) 2002-02-08 2003-09-02 The Regents Of The University Of California A transcription amplification system for molecular imaging
US6730492B2 (en) * 2002-03-09 2004-05-04 Merrimack Pharmaceuticals, Inc. Cell-based screening methods
US20030170850A1 (en) * 2002-03-09 2003-09-11 Cardone Michael H. Cell-based screening methods
EP2218790A3 (en) * 2002-09-06 2010-08-25 Promega Corporation Kits for detecting transferase enzymatic activity
GB0221915D0 (en) 2002-09-20 2002-10-30 Skeland Stein O D Assay
WO2004038039A2 (en) 2002-10-21 2004-05-06 The Regents Of The University Of California Optical imagiong of renilla luciferase reporter gene expression in living organisms
WO2004043992A2 (en) 2002-11-08 2004-05-27 The Regents Of The University Of California Imaging protein-protein interactions in living subjects
JP4485470B2 (ja) * 2002-12-23 2010-06-23 プロメガ コーポレイション ルシフェラーゼ酵素活性を保護するための方法及びキット
US7524674B2 (en) 2003-03-07 2009-04-28 Stanford University Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
CA2445420A1 (en) * 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
US7442518B2 (en) 2003-08-06 2008-10-28 Washington University Imaging regulated protein-protein interactions in cells and living animals by enhanced luciferase protein fragment complementation
US7488583B2 (en) * 2003-09-25 2009-02-10 Odyssey Thera, Inc. Fragment complementation assays for G-protein-coupled receptors and their signaling pathways
EP2298902B1 (en) * 2003-10-10 2015-04-22 Promega Corporation Luciferase biosensor
EP1536020A1 (en) 2003-11-26 2005-06-01 Bayerische Julius-Maximilians-Universität Würzburg Means and methods for optical determination of cAMP in vitro and in vivo
US20060110364A1 (en) 2004-08-20 2006-05-25 Ludwig Institute For Cancer Research Vector-mediated delivery of polynucleotides encoding soluble VEGF receptors
EP1791972A4 (en) 2004-08-23 2009-12-02 Univ Johns Hopkins cAMP REPORTER
US20060048592A1 (en) * 2004-09-09 2006-03-09 Ung Tom T Damping nut for screw-driven mechanism
CA2619686A1 (en) * 2005-08-19 2007-02-22 Commomwealth Scientific And Industrial Research Organisation Arachnocampa luciferases
JP5684984B2 (ja) * 2006-04-03 2015-03-18 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 順列置換及び非順列置換ルシフェラーゼバイオセンサー
CN103230598A (zh) 2006-09-06 2013-08-07 费斯生物制药公司 融合肽治疗组合物
US7812002B2 (en) 2007-03-21 2010-10-12 Quark Pharmaceuticals, Inc. Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer
EP2154159A4 (en) 2007-05-09 2012-03-21 Univ Tokyo INDICATOR FOR ACTIVATED PROTEASE
WO2009049892A1 (en) 2007-10-17 2009-04-23 European Molecular Biology Laboratory (Embl) Polypeptides comprising an annexin core domain, compositions, methods and use thereof
EP2215227A2 (en) * 2007-11-05 2010-08-11 Promega Corporation Hybrid fusion reporter and uses thereof
WO2009140662A1 (en) * 2008-05-15 2009-11-19 Illumina, Inc. Engineered luciferases
ATE542903T1 (de) 2008-05-19 2012-02-15 Promega Corp Luciferase-biosensoren für camp
EP2569423B1 (en) 2010-05-11 2015-12-02 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
JP5501862B2 (ja) 2010-05-24 2014-05-28 株式会社サンユー 金属被膜見本キット
AU2011323418B2 (en) 2010-11-02 2017-07-27 Promega Corporation Novel coelenterazine substrates and methods of use
EP2776573A1 (en) 2011-11-11 2014-09-17 Promega Corporation Mutant protease biosensors with enhanced detection characteristics

Also Published As

Publication number Publication date
WO2009142735A3 (en) 2010-01-14
WO2009142735A2 (en) 2009-11-26
EP2281046B1 (en) 2012-01-25
JP6275635B2 (ja) 2018-02-07
US9045730B2 (en) 2015-06-02
JP2011520466A (ja) 2011-07-21
ATE542903T1 (de) 2012-02-15
JP2015091253A (ja) 2015-05-14
US9879306B2 (en) 2018-01-30
US20090305280A1 (en) 2009-12-10
US20150299765A1 (en) 2015-10-22
EP2281046A2 (en) 2011-02-09

Similar Documents

Publication Publication Date Title
JP6275635B2 (ja) ｃＡＭＰのためのルシフェラーゼバイオセンサー
US9359635B2 (en) Permuted and nonpermuted luciferase biosensors
JP5781789B2 (ja) ルシフェラーゼバイオセンサー
TW200846469A (en) Secreted MLuc7 luciferase and use thereof
CN102080068A (zh) 荧光素酶活性片段及其应用
CN101473031A (zh) 变换和非变换的萤光素酶生物传感器
JP2025522599A (ja) ルシフェラーゼ変異体及びその使用
JPWO2004022600A1 (ja) 分泌型又は膜結合型キメラ蛋白質

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120521

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120521

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140225

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141226

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150113

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20150313

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160606

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20160909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161228

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170310

R150 Certificate of patent or registration of utility model

Ref document number: 6110591

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250